GlassScriptPhysician profile
Phillip H Lee
NPI 1578628731
$14,046.44
in general payments reported to CMS, 2019-2025
41 companies · $2,645 in 2025
The $2,645 reported for 2025 was more than what 82% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,475 · 2020: $1,666 · 2021: $1,564 · 2022: $1,451 · 2023: $2,408 · 2024: $2,838 · 2025: $2,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,684 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,683.96 |
| Education | $207.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,524.63 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,371.14 | 2019-2025 | Ilumya, Absorica Ld, Winlevi |
| Regeneron Healthcare Solutions, INC. | $1,006.24 | 2020-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $982.15 | 2019-2025 | |
| Mannkind Corporation | $951.67 | 2019-2025 | Afrezza |
| Incyte Corporation | $723.98 | 2021-2025 | Opzelura |
| Leo Pharma INC. | $719.54 | 2019-2025 | Adbry, Anzupgo |
| Strata Skin Sciences, INC. | $692.46 | 2019-2025 | Xtrac |
| Novartis Pharmaceuticals Corporation | $603.00 | 2019-2025 | |
| Lilly USA, LLC | $537.15 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $507.35 | 2020-2025 | Nemluvio |
| Pfizer INC. | $442.23 | 2019-2025 | |
| Almirall LLC | $305.89 | 2019-2025 | Seysara |
| Arcutis Biotherapeutics, INC. | $265.42 | 2024-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $242.05 | 2019-2024 | Siliq, Duobrii |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.